36
https://pubmed.ncbi.nlm.nih.gov/38115129
This case report suggests that hepatitis B core-related antigen (HBcrAg) levels may predict hepatitis B virus (HBV) rebound and subsequent HBsAg seroconversion after nucleoside analogue cessation in patients with resolved HBV infection.